US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Savara Inc

5.59

+0.10001.82%

Pre-market: 5.600.0100+0.18%05:37 EDT

Volume:3.04M

Turnover:16.95M

Market Cap:1.14B

PE:-9.67

High:5.64

Open:5.54

Low:5.50

Close:5.49

52wk High:7.01

52wk Low:3.08

Shares:204.66M

Float Shares:198.20M

Volume Ratio:1.85

T/O Rate:1.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5782

EPS(LYR):-0.5344

ROE:-105.48%

ROA:-50.15%

PB:7.96

PE(LYR):-10.46

Loading ...

Overview Company News Filings

Savara Inc. to Relocate Headquarters to Yardley, Pa

Savara Inc. publishes corporate presentation on autoimmune pulmonary alveolar proteinosis and MOLBREEVI Phase 3 data

Savara Q4 EPS $(0.13), Inline

Benzinga Earnings

Earnings Flash (SVRA) Savara Posts Q4 Loss $0.13 a Share, vs. FactSet Est of $0.12 Loss

MT Newswires Live

CORRECTED-Savara Q4 net loss widens as expenses rise

Savara FY 2025 net loss widens 24% to USD 118.84 million as G&A expenses jump 68% to USD 42.06 million

BRIEF-Savara Q4 Net Income USD -32.236 Million

Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

THOMSON REUTERS

Savara Q4 EPS USD -0.13

THOMSON REUTERS

How FDA’s No-Advisory-Committee Path for MOLBREEVI Could Shape Savara (SVRA) Investors’ Outlook

Simply Wall St.

LifeSci Capital Keeps Their Buy Rating on Savara (SVRA)

Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Codexis (CDXS) and Diamedica Therapeutics (DMAC)

Savara Inc. Publishes Corporate Presentation on Autoimmune PAP and MOLBREEVI Molgramostim Inhalation Solution

Savara announces receipt of Day 74 Letter from FDA

BRIEF-Savara Provides Regulatory Update On The MOLBREEVI* Development Program In Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)

Savara Inc - on Track to Submit Maa to UK Mhra by End of Q1 2026

THOMSON REUTERS

Savara Inc - Pdufa Target Action Date for Molbreevi Set for August 22, 2026

THOMSON REUTERS

Savara - Day 74 Letter Received From U.S. Food and Drug Administration Indicated Agency Has No Plans to Convene Advisory Committee

THOMSON REUTERS

Savara Provides Regulatory Update on the Molbreevi* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)

THOMSON REUTERS

Savara says FDA plans no advisory panel for MOLBREEVI as review continues toward Aug. 22, 2026 PDUFA date

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SVRA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","market":"US","secType":"STK","nameCN":"Savara Inc","latestPrice":5.59,"timestamp":1787342400000,"preClose":5.49,"halted":0,"volume":3035363,"hourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.59,"latestTime":"05:37 EDT","volume":104,"amount":582.4,"timestamp":1787564265950,"change":0.01,"changeRate":0.001789,"amplitude":0},"delay":0,"changeRate":0.01821493624772307,"floatShares":198198210,"shares":204657499,"eps":-0.578152,"marketStatus":"Pre-Mkt","change":0.1,"latestTime":"08-24 06:11:35 EDT","open":5.54,"high":5.64,"low":5.5,"amount":16947008.34797,"amplitude":0.025501,"askPrice":6.08,"askSize":100,"bidPrice":5.5,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-0.578152,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.59,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.59,"latestTime":"05:37 EDT","volume":104,"amount":582.4,"timestamp":1787564265950,"change":0.01,"changeRate":0.001789,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.58,"preClose":5.59,"latestTime":"19:46 EDT","volume":1489374,"amount":8325593.89,"timestamp":1787355967321,"change":-0.01,"changeRate":-0.001789,"amplitude":0.001789},"volumeRatio":1.8491506253732195,"impliedVol":1.5911,"impliedVolPercentile":0.656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","floatShares":198198210,"roa":"-50.15%","roe":"-105.48%","lyrEps":-0.534368,"volumeRatio":1.8491506253732195,"shares":204657499,"dividePrice":0,"high":5.64,"amplitude":0.025501,"preClose":5.49,"low":5.5,"week52Low":3.08,"pbRate":"7.96","week52High":7.005,"institutionHeld":0.9863,"latestPrice":5.59,"committee":-0.709402,"eps":-0.578152,"divideRate":0,"volume":3035363,"delay":0,"ttmEps":-0.578152,"open":5.54,"prevYearClose":6.03,"prevWeekClose":5.59,"prevMonthClose":5.46,"prevQuarterClose":6.16,"fiveDayClose":5.38,"twentyDayClose":5.51,"sixtyDayClose":5.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"SVRA","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2026-05-12","symbol":"SVRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2026-03-13","symbol":"SVRA","fiscalQuarterEnding":"2025/12","expectedEps":-0.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773374400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-11-12","symbol":"SVRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.13,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-08-13","symbol":"SVRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1760500800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVRA","date":"2026-08-21","current":-9.668738,"percent":0.315704,"low":-15.250395,"twenty":-11.474987,"median":-7.185996,"eighty":-4.075421,"high":-2.605866,"avg":-7.650958,"sd":3.402302,"marketCap":1395217729},"quantilePoints":[{"date":"2021-08-27","current":-3.542107,"twenty":-11.689386,"median":-4.462032,"eighty":-1.409182,"marketCap":162802328},{"date":"2021-09-03","current":-3.839347,"twenty":-11.217586,"median":-4.410492,"eighty":-1.410882,"marketCap":176464062},{"date":"2021-09-10","current":-3.591647,"twenty":-10.802353,"median":-4.401307,"eighty":-1.415446,"marketCap":165079283},{"date":"2021-09-17","current":-3.443027,"twenty":-10.699669,"median":-4.3851,"eighty":-1.417737,"marketCap":158248416},{"date":"2021-09-24","current":-3.220097,"twenty":-10.679132,"median":-4.375718,"eighty":-1.417751,"marketCap":148002116},{"date":"2021-10-01","current":-3.319177,"twenty":-10.442959,"median":-4.367971,"eighty":-1.417751,"marketCap":152556027},{"date":"2021-10-08","current":-3.294407,"twenty":-10.432691,"median":-4.350129,"eighty":-1.430744,"marketCap":151417550},{"date":"2021-10-15","current":-3.195327,"twenty":-10.391617,"median":-4.34948,"eighty":-1.433771,"marketCap":146863638},{"date":"2021-10-22","current":-2.997168,"twenty":-10.330007,"median":-4.326588,"eighty":-1.433771,"marketCap":137755816},{"date":"2021-10-29","current":-2.873318,"twenty":-10.330007,"median":-4.278431,"eighty":-1.441065,"marketCap":132063427},{"date":"2021-11-05","current":-2.972398,"twenty":-10.206786,"median":-4.233525,"eighty":-1.441781,"marketCap":136617338},{"date":"2021-11-12","current":-2.831373,"twenty":-10.199059,"median":-4.210516,"eighty":-1.441781,"marketCap":128671754},{"date":"2021-11-19","current":-2.706091,"twenty":-10.024453,"median":-4.202795,"eighty":-1.441781,"marketCap":122978313},{"date":"2021-11-26","current":-2.881486,"twenty":-9.917635,"median":-4.190578,"eighty":-1.443357,"marketCap":130949130},{"date":"2021-12-03","current":-2.655978,"twenty":-9.874496,"median":-4.159412,"eighty":-1.454242,"marketCap":120700937},{"date":"2021-12-10","current":-2.605866,"twenty":-9.788221,"median":-4.129491,"eighty":-1.457614,"marketCap":118423561},{"date":"2021-12-17","current":-2.956655,"twenty":-9.743029,"median":-4.105056,"eighty":-1.462169,"marketCap":134365194},{"date":"2021-12-23","current":-3.232276,"twenty":-9.69989,"median":-4.096593,"eighty":-1.463261,"marketCap":146890763},{"date":"2021-12-31","current":-3.106994,"twenty":-9.673793,"median":-4.05298,"eighty":-1.463326,"marketCap":141197323},{"date":"2022-01-07","current":-3.282388,"twenty":-9.655788,"median":-4.006708,"eighty":-1.46638,"marketCap":149168139},{"date":"2022-01-14","current":-3.257332,"twenty":-9.570476,"median":-3.985431,"eighty":-1.469278,"marketCap":148029451},{"date":"2022-01-21","current":-2.881486,"twenty":-9.517068,"median":-3.938427,"eighty":-1.471159,"marketCap":130949130},{"date":"2022-01-28","current":-2.85643,"twenty":-9.509957,"median":-3.909431,"eighty":-1.473381,"marketCap":129810442},{"date":"2022-02-04","current":-3.081937,"twenty":-9.504428,"median":-3.896613,"eighty":-1.474842,"marketCap":140058635},{"date":"2022-02-11","current":-3.006768,"twenty":-9.486889,"median":-3.881309,"eighty":-1.476376,"marketCap":136642570},{"date":"2022-02-18","current":-2.78126,"twenty":-9.460663,"median":-3.84849,"eighty":-1.477623,"marketCap":126394377},{"date":"2022-02-25","current":-2.756204,"twenty":-9.445342,"median":-3.839347,"eighty":-1.479961,"marketCap":125255689},{"date":"2022-03-04","current":-2.756204,"twenty":-9.43811,"median":-3.808811,"eighty":-1.482282,"marketCap":125255689},{"date":"2022-03-11","current":-2.706091,"twenty":-9.431308,"median":-3.768435,"eighty":-1.484092,"marketCap":122978313},{"date":"2022-03-18","current":-3.257332,"twenty":-9.410249,"median":-3.731396,"eighty":-1.486429,"marketCap":148029451},{"date":"2022-03-25","current":-3.081937,"twenty":-9.366646,"median":-3.708504,"eighty":-1.4958,"marketCap":140058635},{"date":"2022-04-01","current":-3.499619,"twenty":-9.311844,"median":-3.597148,"eighty":-1.497733,"marketCap":150532615},{"date":"2022-04-08","current":-3.499619,"twenty":-9.262945,"median":-3.56335,"eighty":-1.505113,"marketCap":150532615},{"date":"2022-04-14","current":-3.340545,"twenty":-9.257117,"median":-3.542107,"eighty":-1.505113,"marketCap":143690223},{"date":"2022-04-22","current":-3.261009,"twenty":-9.233589,"median":-3.521352,"eighty":-1.505113,"marketCap":140269027},{"date":"2022-04-29","current":-3.128447,"twenty":-9.200262,"median":-3.499619,"eighty":-1.510539,"marketCap":134567034},{"date":"2022-05-06","current":-3.048911,"twenty":-9.104739,"median":-3.444811,"eighty":-1.510539,"marketCap":131145839},{"date":"2022-05-13","current":-3.468662,"twenty":-9.032946,"median":-3.420082,"eighty":-1.510539,"marketCap":142551588},{"date":"2022-05-20","current":-3.801653,"twenty":-8.916829,"median":-3.420082,"eighty":-1.510539,"marketCap":156236541},{"date":"2022-05-27","current":-3.662907,"twenty":-8.862364,"median":-3.420082,"eighty":-1.510539,"marketCap":150534477},{"date":"2022-06-03","current":-3.746155,"twenty":-8.73459,"median":-3.420082,"eighty":-1.510539,"marketCap":153955715},{"date":"2022-06-10","current":-3.91265,"twenty":-8.186259,"median":-3.420082,"eighty":-1.510539,"marketCap":160798192},{"date":"2022-06-17","current":-3.607408,"twenty":-7.972847,"median":-3.420082,"eighty":-1.510539,"marketCap":148253652},{"date":"2022-06-24","current":-4.356639,"twenty":-7.810479,"median":-3.420082,"eighty":-1.509183,"marketCap":179044795},{"date":"2022-07-01","current":-4.273391,"twenty":-7.710825,"median":-3.420082,"eighty":-1.509183,"marketCap":175623557},{"date":"2022-07-08","current":-5.161369,"twenty":-7.620641,"median":-3.420082,"eighty":-1.509183,"marketCap":212116764},{"date":"2022-07-15","current":-4.939374,"twenty":-7.600302,"median":-3.420082,"eighty":-1.509183,"marketCap":202993462},{"date":"2022-07-22","current":-4.967124,"twenty":-7.582154,"median":-3.420082,"eighty":-1.509183,"marketCap":204133875},{"date":"2022-07-29","current":-4.495386,"twenty":-7.569092,"median":-3.420082,"eighty":-1.509183,"marketCap":184746859},{"date":"2022-08-05","current":-4.828377,"twenty":-7.552842,"median":-3.420082,"eighty":-1.509183,"marketCap":198431811},{"date":"2022-08-12","current":-4.959637,"twenty":-7.50861,"median":-3.420082,"eighty":-1.509183,"marketCap":195012917},{"date":"2022-08-19","current":-4.785614,"twenty":-7.441671,"median":-3.420082,"eighty":-1.509183,"marketCap":188170359},{"date":"2022-08-26","current":-4.147533,"twenty":-7.384548,"median":-3.420082,"eighty":-1.509183,"marketCap":163080978},{"date":"2022-09-02","current":-4.20554,"twenty":-7.353882,"median":-3.420082,"eighty":-1.509183,"marketCap":165361830},{"date":"2022-09-09","current":-4.292551,"twenty":-7.292493,"median":-3.420082,"eighty":-1.509183,"marketCap":168783110},{"date":"2022-09-16","current":-4.350559,"twenty":-7.23411,"median":-3.420082,"eighty":-1.509183,"marketCap":171063963},{"date":"2022-09-23","current":-4.118529,"twenty":-7.185667,"median":-3.420082,"eighty":-1.509183,"marketCap":161940551},{"date":"2022-09-30","current":-4.495577,"twenty":-7.131131,"median":-3.420082,"eighty":-1.509183,"marketCap":176766095},{"date":"2022-10-07","current":-3.799488,"twenty":-6.953497,"median":-3.420082,"eighty":-1.509183,"marketCap":149395861},{"date":"2022-10-14","current":-3.538454,"twenty":-6.76637,"median":-3.420082,"eighty":-1.509183,"marketCap":139132023},{"date":"2022-10-21","current":-3.567458,"twenty":-6.674372,"median":-3.418257,"eighty":-1.509183,"marketCap":140272449},{"date":"2022-10-28","current":-3.596462,"twenty":-6.528013,"median":-3.409536,"eighty":-1.509183,"marketCap":141412876},{"date":"2022-11-04","current":-3.306424,"twenty":-6.435942,"median":-3.39357,"eighty":-1.509183,"marketCap":130008611},{"date":"2022-11-11","current":-3.407341,"twenty":-6.335605,"median":-3.393436,"eighty":-1.509183,"marketCap":133431481},{"date":"2022-11-18","current":-3.989793,"twenty":-6.251734,"median":-3.393436,"eighty":-1.509183,"marketCap":156240281},{"date":"2022-11-25","current":-4.193651,"twenty":-6.184618,"median":-3.393436,"eighty":-1.509183,"marketCap":164223361},{"date":"2022-12-02","current":-4.717857,"twenty":-6.013388,"median":-3.393436,"eighty":-1.509183,"marketCap":184751281},{"date":"2022-12-09","current":-4.601367,"twenty":-5.8031,"median":-3.393436,"eighty":-1.509183,"marketCap":180189521},{"date":"2022-12-16","current":-4.426631,"twenty":-5.727576,"median":-3.393436,"eighty":-1.509183,"marketCap":173346881},{"date":"2022-12-23","current":-4.368386,"twenty":-5.610336,"median":-3.393436,"eighty":-1.509183,"marketCap":171066001},{"date":"2022-12-30","current":-4.513999,"twenty":-5.561222,"median":-3.393436,"eighty":-1.509183,"marketCap":176768201},{"date":"2023-01-06","current":-5.067328,"twenty":-5.484318,"median":-3.393436,"eighty":-1.509183,"marketCap":198436561},{"date":"2023-01-13","current":-5.329431,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":208700521},{"date":"2023-01-20","current":-6.086618,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":238351962},{"date":"2023-01-27","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-03","current":-6.872928,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":269143842},{"date":"2023-02-10","current":-7.105908,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":278267362},{"date":"2023-02-17","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-24","current":-7.368011,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":288531322},{"date":"2023-03-03","current":-6.90205,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":270284282},{"date":"2023-03-10","current":-6.144863,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":240632842},{"date":"2023-03-17","current":-5.911883,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":231509322},{"date":"2023-03-24","current":-5.824515,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":228088002},{"date":"2023-03-31","current":-5.830308,"twenty":-5.430741,"median":-3.393436,"eighty":-1.510539,"marketCap":222426235},{"date":"2023-04-06","current":-5.052933,"twenty":-5.408841,"median":-3.393436,"eighty":-1.510539,"marketCap":192769403},{"date":"2023-04-14","current":-5.232327,"twenty":-5.29765,"median":-3.393436,"eighty":-1.509183,"marketCap":199613288},{"date":"2023-04-21","current":-5.501418,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":209879114},{"date":"2023-04-28","current":-5.561216,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":212160408},{"date":"2023-05-05","current":-5.680813,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":216722998},{"date":"2023-05-12","current":-5.800409,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":221285587},{"date":"2023-05-19","current":-7.226612,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":292005724},{"date":"2023-05-26","current":-7.283156,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":294290486},{"date":"2023-06-02","current":-8.271181,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":334213614},{"date":"2023-06-09","current":-8.32764,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":336494936},{"date":"2023-06-16","current":-8.976913,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":362730134},{"date":"2023-06-23","current":-8.242952,"twenty":-5.335182,"median":-3.393436,"eighty":-1.507826,"marketCap":333072953},{"date":"2023-06-30","current":-7.621907,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":307978416},{"date":"2023-07-07","current":-8.497015,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":343338900},{"date":"2023-07-14","current":-9.132174,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":369003768},{"date":"2023-07-21","current":-11.632389,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":470029958},{"date":"2023-07-28","current":-10.963861,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":443016742},{"date":"2023-08-04","current":-11.933227,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":482185905},{"date":"2023-08-11","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-08-18","current":-10.893423,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":464996637},{"date":"2023-08-25","current":-11.590095,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":494734794},{"date":"2023-09-01","current":-11.463427,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":489327856},{"date":"2023-09-08","current":-12.033432,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":513659075},{"date":"2023-09-15","current":-11.653429,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":497438262},{"date":"2023-09-22","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-09-29","current":-11.970098,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":510955606},{"date":"2023-10-06","current":-11.938431,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":509603872},{"date":"2023-10-13","current":-10.355085,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":442017152},{"date":"2023-10-20","current":-10.101749,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":431203276},{"date":"2023-10-27","current":-11.115091,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":474458777},{"date":"2023-11-03","current":-11.400093,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":486624387},{"date":"2023-11-10","current":-9.426398,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":460941433},{"date":"2023-11-17","current":-9.977799,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":487904391},{"date":"2023-11-24","current":-10.517513,"twenty":-5.313191,"median":-3.381076,"eighty":-1.505113,"marketCap":514295891},{"date":"2023-12-01","current":-10.655902,"twenty":-5.338428,"median":-3.381076,"eighty":-1.505113,"marketCap":521062942},{"date":"2023-12-08","current":-11.126422,"twenty":-5.415071,"median":-3.393436,"eighty":-1.505113,"marketCap":544070916},{"date":"2023-12-15","current":-12.316562,"twenty":-5.475519,"median":-3.393436,"eighty":-1.505113,"marketCap":602267556},{"date":"2023-12-22","current":-12.980826,"twenty":-5.561216,"median":-3.393436,"eighty":-1.505113,"marketCap":634749402},{"date":"2023-12-29","current":-13.340635,"twenty":-5.590213,"median":-3.381076,"eighty":-1.505113,"marketCap":652343735},{"date":"2024-01-05","current":-12.039785,"twenty":-5.620881,"median":-3.368717,"eighty":-1.505113,"marketCap":588733454},{"date":"2024-01-12","current":-11.596942,"twenty":-5.710712,"median":-3.368717,"eighty":-1.505113,"marketCap":567078890},{"date":"2024-01-19","current":-11.818364,"twenty":-5.829149,"median":-3.367888,"eighty":-1.505113,"marketCap":577906172},{"date":"2024-01-26","current":-13.783478,"twenty":-5.911883,"median":-3.368717,"eighty":-1.505113,"marketCap":673998299},{"date":"2024-02-02","current":-14.0049,"twenty":-6.006255,"median":-3.368717,"eighty":-1.505113,"marketCap":684825581},{"date":"2024-02-09","current":-13.202247,"twenty":-6.098621,"median":-3.368717,"eighty":-1.505113,"marketCap":645576684},{"date":"2024-02-16","current":-13.755801,"twenty":-6.227598,"median":-3.368717,"eighty":-1.505113,"marketCap":672644889},{"date":"2024-02-23","current":-13.589734,"twenty":-6.366195,"median":-3.368717,"eighty":-1.505113,"marketCap":664524427},{"date":"2024-03-01","current":-13.977222,"twenty":-6.479218,"median":-3.381076,"eighty":-1.505113,"marketCap":683472171},{"date":"2024-03-08","current":-13.831517,"twenty":-6.90205,"median":-3.381076,"eighty":-1.505113,"marketCap":756556324},{"date":"2024-03-15","current":-11.769541,"twenty":-7.041838,"median":-3.381076,"eighty":-1.505113,"marketCap":643770337},{"date":"2024-03-22","current":-12.350441,"twenty":-7.184539,"median":-3.381076,"eighty":-1.505113,"marketCap":675544409},{"date":"2024-03-28","current":-12.249415,"twenty":-7.248225,"median":-3.381076,"eighty":-1.505113,"marketCap":670018483},{"date":"2024-04-05","current":-11.643258,"twenty":-7.32724,"median":-3.368717,"eighty":-1.505113,"marketCap":636862930},{"date":"2024-04-12","current":-13.486984,"twenty":-7.368011,"median":-3.368717,"eighty":-1.505113,"marketCap":737711072},{"date":"2024-04-19","current":-12.100371,"twenty":-7.497698,"median":-3.368717,"eighty":-1.505113,"marketCap":661866110},{"date":"2024-04-26","current":-11.241472,"twenty":-7.68836,"median":-3.381076,"eighty":-1.505113,"marketCap":614886052},{"date":"2024-05-03","current":-11.822492,"twenty":-7.80485,"median":-3.381076,"eighty":-1.505113,"marketCap":646666679},{"date":"2024-05-10","current":-10.864479,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":700617677},{"date":"2024-05-17","current":-10.114466,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":652251565},{"date":"2024-05-24","current":-8.935874,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":576247675},{"date":"2024-05-31","current":-8.8073,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":567956342},{"date":"2024-06-07","current":-8.614439,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":555519341},{"date":"2024-06-14","current":-8.700155,"twenty":-8.073576,"median":-3.393436,"eighty":-1.505113,"marketCap":561046897},{"date":"2024-06-21","current":-7.971571,"twenty":-8.211511,"median":-3.393487,"eighty":-1.505113,"marketCap":514062674},{"date":"2024-06-28","current":-8.164431,"twenty":-8.254244,"median":-3.407341,"eighty":-1.505113,"marketCap":526499674},{"date":"2024-07-05","current":-11.041081,"twenty":-8.350223,"median":-3.420082,"eighty":-1.505113,"marketCap":712006195},{"date":"2024-07-12","current":-12.928009,"twenty":-8.542182,"median":-3.422439,"eighty":-1.505113,"marketCap":833688547},{"date":"2024-07-15","current":-12.469027,"twenty":-8.611735,"median":-3.435172,"eighty":-1.505113,"marketCap":804090137},{"date":"2024-08-02","current":-11.576561,"twenty":-8.657297,"median":-3.483445,"eighty":-1.495778,"marketCap":746537673},{"date":"2024-08-09","current":-10.327108,"twenty":-8.743013,"median":-3.517337,"eighty":-1.495778,"marketCap":665964224},{"date":"2024-08-16","current":-9.860251,"twenty":-8.835767,"median":-3.540281,"eighty":-1.495778,"marketCap":742348719},{"date":"2024-08-23","current":-9.64162,"twenty":-8.935874,"median":-3.567458,"eighty":-1.495778,"marketCap":725888659},{"date":"2024-08-30","current":-9.226222,"twenty":-8.976913,"median":-3.594054,"eighty":-1.495778,"marketCap":694614544},{"date":"2024-09-06","current":-9.92584,"twenty":-9.085876,"median":-3.621282,"eighty":-1.495778,"marketCap":747286737},{"date":"2024-09-13","current":-9.269948,"twenty":-9.204358,"median":-3.662907,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-09-20","current":-10.144471,"twenty":-9.278737,"median":-3.69958,"eighty":-1.495778,"marketCap":763746797},{"date":"2024-09-27","current":-9.269948,"twenty":-9.335537,"median":-3.746155,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-10-04","current":-8.329835,"twenty":-9.335537,"median":-3.778343,"eighty":-1.505113,"marketCap":627128297},{"date":"2024-10-11","current":-7.87071,"twenty":-9.335537,"median":-3.801653,"eighty":-1.528294,"marketCap":592562170},{"date":"2024-10-18","current":-7.980026,"twenty":-9.335537,"median":-3.834375,"eighty":-1.549946,"marketCap":600792200},{"date":"2024-10-25","current":-7.30227,"twenty":-9.335537,"median":-3.860545,"eighty":-1.556351,"marketCap":549766014},{"date":"2024-10-31","current":-7.958163,"twenty":-9.335537,"median":-3.893503,"eighty":-1.562755,"marketCap":599146194},{"date":"2024-11-08","current":-8.78896,"twenty":-9.353709,"median":-3.91265,"eighty":-1.576715,"marketCap":661694424},{"date":"2024-11-15","current":-6.601047,"twenty":-9.353709,"median":-3.968149,"eighty":-1.588088,"marketCap":547464431},{"date":"2024-11-22","current":-6.704512,"twenty":-9.353709,"median":-4.002514,"eighty":-1.599903,"marketCap":556045378},{"date":"2024-11-29","current":-6.952827,"twenty":-9.353709,"median":-4.031518,"eighty":-1.612485,"marketCap":576639651},{"date":"2024-12-06","current":-7.449457,"twenty":-9.353709,"median":-4.06865,"eighty":-1.643185,"marketCap":617828198},{"date":"2024-12-13","current":-6.932134,"twenty":-9.353709,"median":-4.119828,"eighty":-1.655744,"marketCap":574923462},{"date":"2024-12-20","current":-8.157595,"twenty":-9.353709,"median":-4.147533,"eighty":-1.664831,"marketCap":676558329},{"date":"2024-12-27","current":-8.283874,"twenty":-9.353709,"median":-4.176536,"eighty":-1.687705,"marketCap":687031368},{"date":"2025-01-03","current":-7.753504,"twenty":-9.353709,"median":-4.193651,"eighty":-1.695455,"marketCap":643044603},{"date":"2025-01-10","current":-7.677737,"twenty":-9.371881,"median":-4.217893,"eighty":-1.693654,"marketCap":636760780},{"date":"2025-01-17","current":-7.349413,"twenty":-9.371881,"median":-4.24322,"eighty":-1.693654,"marketCap":609530878},{"date":"2025-01-24","current":-7.273645,"twenty":-9.371881,"median":-4.263547,"eighty":-1.693654,"marketCap":603247055},{"date":"2025-01-31","current":-7.0716,"twenty":-9.371881,"median":-4.295751,"eighty":-1.693654,"marketCap":586490192},{"date":"2025-02-07","current":-7.172623,"twenty":-9.371881,"median":-4.324072,"eighty":-1.708924,"marketCap":594868623},{"date":"2025-02-14","current":-7.147367,"twenty":-9.371881,"median":-4.350344,"eighty":-1.740807,"marketCap":592774015},{"date":"2025-02-21","current":-6.793787,"twenty":-9.371881,"median":-4.368299,"eighty":-1.740807,"marketCap":563449506},{"date":"2025-02-28","current":-6.212905,"twenty":-9.371881,"median":-4.377594,"eighty":-1.761302,"marketCap":515273526},{"date":"2025-03-07","current":-6.566485,"twenty":-9.390054,"median":-4.397509,"eighty":-1.766426,"marketCap":544598035},{"date":"2025-03-14","current":-6.970577,"twenty":-9.390054,"median":-4.426631,"eighty":-1.849687,"marketCap":578111761},{"date":"2025-03-21","current":-7.223134,"twenty":-9.390054,"median":-4.455754,"eighty":-2.630922,"marketCap":599057839},{"date":"2025-03-28","current":-6.073163,"twenty":-9.390054,"median":-4.529252,"eighty":-2.706091,"marketCap":582300976},{"date":"2025-04-04","current":-6.365989,"twenty":-9.390054,"median":-4.555508,"eighty":-2.731148,"marketCap":610377439},{"date":"2025-04-11","current":-5.795246,"twenty":-9.371881,"median":-4.597373,"eighty":-2.756204,"marketCap":555653944},{"date":"2025-04-17","current":-6.431845,"twenty":-9.371881,"median":-4.606018,"eighty":-2.78126,"marketCap":616691688},{"date":"2025-04-25","current":-7.178202,"twenty":-9.390054,"median":-4.631607,"eighty":-2.806317,"marketCap":688253181},{"date":"2025-05-02","current":-7.15625,"twenty":-9.390054,"median":-4.638411,"eighty":-2.831373,"marketCap":686148431},{"date":"2025-05-09","current":-7.072289,"twenty":-9.390054,"median":-4.657196,"eighty":-2.85643,"marketCap":678098122},{"date":"2025-05-16","current":-6.413042,"twenty":-9.390054,"median":-4.661881,"eighty":-2.873318,"marketCap":655246189},{"date":"2025-05-23","current":-6.041869,"twenty":-9.390054,"median":-4.688734,"eighty":-2.888127,"marketCap":617321972},{"date":"2025-05-30","current":-4.61904,"twenty":-9.390054,"median":-4.689631,"eighty":-2.910465,"marketCap":471945808},{"date":"2025-06-06","current":-4.90773,"twenty":-9.390054,"median":-4.717857,"eighty":-2.931599,"marketCap":501442421},{"date":"2025-06-13","current":-4.660282,"twenty":-9.390054,"median":-4.745129,"eighty":-2.956655,"marketCap":476159610},{"date":"2025-06-20","current":-4.268488,"twenty":-9.408226,"median":-4.745129,"eighty":-2.972398,"marketCap":436128492},{"date":"2025-06-27","current":-4.557178,"twenty":-9.408226,"median":-4.745129,"eighty":-2.997168,"marketCap":465625105},{"date":"2025-07-03","current":-4.515937,"twenty":-9.408226,"median":-4.745129,"eighty":-3.006768,"marketCap":461411303},{"date":"2025-07-11","current":-4.742764,"twenty":-9.408226,"median":-4.751796,"eighty":-3.031824,"marketCap":484587213},{"date":"2025-07-18","current":-4.825247,"twenty":-9.408226,"median":-4.769744,"eighty":-3.056881,"marketCap":493014817},{"date":"2025-07-25","current":-5.258282,"twenty":-9.408226,"median":-4.785378,"eighty":-3.076726,"marketCap":537259737},{"date":"2025-08-01","current":-5.340765,"twenty":-9.408226,"median":-4.825247,"eighty":-3.084799,"marketCap":545687340},{"date":"2025-08-08","current":-5.423248,"twenty":-9.408226,"median":-4.864376,"eighty":-3.106994,"marketCap":554114944},{"date":"2025-08-15","current":-5.747899,"twenty":-9.408226,"median":-4.911625,"eighty":-3.127725,"marketCap":634177179},{"date":"2025-08-22","current":-5.824283,"twenty":-9.408226,"median":-4.939374,"eighty":-3.147266,"marketCap":642604783},{"date":"2025-08-29","current":-6.244395,"twenty":-9.408226,"median":-4.968358,"eighty":-3.163746,"marketCap":688956604},{"date":"2025-09-05","current":-6.836371,"twenty":-9.426398,"median":-5.052933,"eighty":-3.178816,"marketCap":754270532},{"date":"2025-09-12","current":-6.855467,"twenty":-9.408226,"median":-5.072724,"eighty":-3.195327,"marketCap":756377433},{"date":"2025-09-19","current":-6.874563,"twenty":-9.408226,"median":-5.134558,"eighty":-3.195327,"marketCap":758484334},{"date":"2025-09-26","current":-6.626315,"twenty":-9.408226,"median":-5.15883,"eighty":-3.205742,"marketCap":731094622},{"date":"2025-10-03","current":-6.664507,"twenty":-9.408226,"median":-5.198379,"eighty":-3.220097,"marketCap":735308424},{"date":"2025-10-10","current":-6.530835,"twenty":-9.408226,"median":-5.24421,"eighty":-3.232276,"marketCap":720560118},{"date":"2025-10-17","current":-6.836371,"twenty":-9.408226,"median":-5.289213,"eighty":-3.245577,"marketCap":754270532},{"date":"2025-10-24","current":-7.867556,"twenty":-9.408226,"median":-5.346344,"eighty":-3.257332,"marketCap":868043183},{"date":"2025-10-31","current":-8.211284,"twenty":-9.408226,"median":-5.417485,"eighty":-3.269637,"marketCap":905967399},{"date":"2025-11-07","current":-8.627061,"twenty":-9.408226,"median":-5.493264,"eighty":-3.282388,"marketCap":951840860},{"date":"2025-11-14","current":-9.317583,"twenty":-9.418263,"median":-5.561814,"eighty":-3.307084,"marketCap":1028027528},{"date":"2025-11-21","current":-9.745075,"twenty":-9.444852,"median":-5.606096,"eighty":-3.315062,"marketCap":1126969144},{"date":"2025-11-28","current":-13.125593,"twenty":-9.545423,"median":-5.665864,"eighty":-3.336451,"marketCap":1517909190},{"date":"2025-12-05","current":-13.292532,"twenty":-9.616636,"median":-5.72393,"eighty":-3.357699,"marketCap":1537214871},{"date":"2025-12-12","current":-14.481974,"twenty":-9.680973,"median":-5.814735,"eighty":-3.36739,"marketCap":1674767851},{"date":"2025-12-19","current":-12.645643,"twenty":-9.812152,"median":-5.830308,"eighty":-3.393446,"marketCap":1462405356},{"date":"2025-12-26","current":-13.355134,"twenty":-9.912722,"median":-5.859766,"eighty":-3.396324,"marketCap":1544454502},{"date":"2026-01-02","current":-12.583041,"twenty":-10.058665,"median":-5.911883,"eighty":-3.418622,"marketCap":1455165726},{"date":"2026-01-09","current":-12.019621,"twenty":-10.141582,"median":-5.999939,"eighty":-3.422439,"marketCap":1390009052},{"date":"2026-01-16","current":-12.27003,"twenty":-10.265424,"median":-6.039292,"eighty":-3.450393,"marketCap":1418967574},{"date":"2026-01-23","current":-13.480339,"twenty":-10.320481,"median":-6.082171,"eighty":-3.481646,"marketCap":1558933763},{"date":"2026-01-30","current":-11.644008,"twenty":-10.355085,"median":-6.120046,"eighty":-3.517337,"marketCap":1346571269},{"date":"2026-02-06","current":-11.024995,"twenty":-10.513189,"median":-6.1897,"eighty":-3.539185,"marketCap":1274985540},{"date":"2026-02-13","current":-12.456535,"twenty":-10.658057,"median":-6.270837,"eighty":-3.567458,"marketCap":1440535988},{"date":"2026-02-20","current":-12.221506,"twenty":-10.788754,"median":-6.304726,"eighty":-3.59261,"marketCap":1413356064},{"date":"2026-02-27","current":-12.755663,"twenty":-10.863582,"median":-6.365989,"eighty":-3.635157,"marketCap":1475128619},{"date":"2026-03-06","current":-11.730082,"twenty":-10.950423,"median":-6.398917,"eighty":-3.662907,"marketCap":1356525313},{"date":"2026-03-13","current":-11.366855,"twenty":-11.041081,"median":-6.437781,"eighty":-3.70985,"marketCap":1314519975},{"date":"2026-03-20","current":-10.996658,"twenty":-11.102424,"median":-6.471176,"eighty":-3.70985,"marketCap":1306809788},{"date":"2026-03-27","current":-11.18846,"twenty":-11.124156,"median":-6.558208,"eighty":-3.713082,"marketCap":1329602982},{"date":"2026-04-02","current":-11.891734,"twenty":-11.144755,"median":-6.577787,"eighty":-3.731396,"marketCap":1413178027},{"date":"2026-04-10","current":-12.509763,"twenty":-11.235196,"median":-6.607458,"eighty":-3.731396,"marketCap":1486622763},{"date":"2026-04-17","current":-12.032162,"twenty":-11.266721,"median":-6.643922,"eighty":-3.731396,"marketCap":1429866065},{"date":"2026-04-24","current":-10.538809,"twenty":-11.291542,"median":-6.694014,"eighty":-3.731396,"marketCap":1252400418},{"date":"2026-05-01","current":-11.178817,"twenty":-11.291542,"median":-6.721333,"eighty":-3.731396,"marketCap":1328457124},{"date":"2026-05-08","current":-11.011526,"twenty":-11.307445,"median":-6.744587,"eighty":-3.746155,"marketCap":1308576748},{"date":"2026-05-15","current":-10.321688,"twenty":-11.307445,"median":-6.795983,"eighty":-3.771168,"marketCap":1336472764},{"date":"2026-05-22","current":-9.910387,"twenty":-11.307445,"median":-6.836371,"eighty":-3.771168,"marketCap":1283216733},{"date":"2026-05-29","current":-9.969144,"twenty":-11.310289,"median":-6.869554,"eighty":-3.770484,"marketCap":1290824738},{"date":"2026-06-05","current":-10.380445,"twenty":-11.307445,"median":-6.884111,"eighty":-3.771168,"marketCap":1344080768},{"date":"2026-06-12","current":-10.321688,"twenty":-11.307445,"median":-6.916951,"eighty":-3.771168,"marketCap":1336472764},{"date":"2026-06-18","current":-10.537131,"twenty":-11.307445,"median":-6.945321,"eighty":-3.771168,"marketCap":1364368780},{"date":"2026-06-26","current":-11.810204,"twenty":-11.366855,"median":-6.960295,"eighty":-3.770484,"marketCap":1529208874},{"date":"2026-07-02","current":-11.868962,"twenty":-11.430954,"median":-6.995833,"eighty":-3.770484,"marketCap":1536816878},{"date":"2026-07-10","current":-12.319434,"twenty":-11.465257,"median":-7.021088,"eighty":-3.770484,"marketCap":1595144912},{"date":"2026-07-17","current":-10.811331,"twenty":-11.465257,"median":-7.068444,"eighty":-3.801653,"marketCap":1399872800},{"date":"2026-07-24","current":-11.261803,"twenty":-11.465257,"median":-7.0716,"eighty":-3.829402,"marketCap":1458200833},{"date":"2026-07-31","current":-10.850503,"twenty":-11.474987,"median":-7.100696,"eighty":-3.857152,"marketCap":1404944803},{"date":"2026-08-07","current":-11.340146,"twenty":-11.474987,"median":-7.128205,"eighty":-3.94329,"marketCap":1468344839},{"date":"2026-08-14","current":-9.613933,"twenty":-11.474987,"median":-7.15625,"eighty":-4.025717,"marketCap":1339307365},{"date":"2026-08-21","current":-10.015273,"twenty":-11.474987,"median":-7.185996,"eighty":-4.075421,"marketCap":1395217729}],"updateTime":1787524677196},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVRA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619192444","title":"Savara Inc. to Relocate Headquarters to Yardley, Pa","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192444","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192444?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:33","pubTimestamp":1773405183,"startTime":"0","endTime":"0","summary":"Savara Inc. said it plans to relocate its headquarters to a new leased office at 19 W. College Avenue, Suite 200, Yardley, Pennsylvania. The company entered into the lease on March 10, 2026, for about 10,795 square feet, with the term set to run from July 1, 2026 through December 1, 2031.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL5TGN0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619319253","title":"Savara Inc. publishes corporate presentation on autoimmune pulmonary alveolar proteinosis and MOLBREEVI Phase 3 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2619319253","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619319253?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:20","pubTimestamp":1773404417,"startTime":"0","endTime":"0","summary":"Savara released a corporate presentation outlining its focus on autoimmune pulmonary alveolar proteinosis, a rare lung disease caused by GM-CSF autoantibodies that impair surfactant clearance. The presentation said there are no approved drugs in the U.S. or Europe for autoimmune PAP and described whole lung lavage as the current invasive treatment option. It highlighted Phase 3 IMPALA-2 data for MOLBREEVI , reporting a primary endpoint p-value of 0.0007 for change from baseline in DLCO% at Week 24 versus placebo. Savara also reported a Week 24 p-value of 0.0072 for change from baseline in SGRQ Total Score versus placebo.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL5YPj5V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619543192","title":"Savara Q4 EPS $(0.13), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2619543192","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619543192?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:20","pubTimestamp":1773404408,"startTime":"0","endTime":"0","summary":"Savara (NASDAQ:SVRA) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate. This is unchanged from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51237669/savara-q4-eps-0-13-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","TQQQ","QID","MNQmain","PSQ","QLD","SQQQ","JEPQ","USAW.SI","NVIW.SI","BK4139","NQmain","QQQY","USJW.SI","GPIQ","SVRA","QQQE","QYLG","QQQJ","TSYW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619319286","title":"Earnings Flash (SVRA) Savara Posts Q4 Loss $0.13 a Share, vs. FactSet Est of $0.12 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2619319286","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619319286?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:16","pubTimestamp":1773404197,"startTime":"0","endTime":"0","summary":"Earnings Flash (SVRA) Savara Posts Q4 Loss $0.13 a Share, vs. FactSet Est of $0.12 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619192854","title":"CORRECTED-Savara Q4 net loss widens as expenses rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192854","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192854?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:15","pubTimestamp":1773404127,"startTime":"0","endTime":"0","summary":"CORRECTED-Savara Q4 net loss widens as expenses riseCorrects first bullet of Result Drivers to clarify R&D expenses increased for the full yearOverviewUS rare disease drug developer's Q4 net loss wide","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL1N4010I6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619619474","title":"Savara FY 2025 net loss widens 24% to USD 118.84 million as G&A expenses jump 68% to USD 42.06 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619619474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619619474?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:10","pubTimestamp":1773403810,"startTime":"0","endTime":"0","summary":"Savara reported a Q4 net loss of USD 32.24 million, or USD 0.13 per share. Research and development expenses in Q4 were USD 20.9 million, down 10%. General and administrative expenses in Q4 were USD 12.49 million, up 59%. For FY 2025, net loss attributable to common stockholders was USD 118.84 million, or USD 0.53 per share, while general and administrative expenses rose 68% to USD 42.06 million due to higher personnel costs tied to workforce expansion, additional commercial activities, and expanded patient advocacy and medical affairs. Savara ended FY 2025 with cash, cash equivalents and short-term investments of USD 235.7 million, and said it has a PDUFA date of August 22 for MOLBREEVI and expects onboarding of a market development team to be complete in Q2.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL8SsmLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619719440","title":"BRIEF-Savara Q4 Net Income USD -32.236 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619719440","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619719440?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:05","pubTimestamp":1773403545,"startTime":"0","endTime":"0","summary":"BRIEF-Savara Q4 Net Income USD -32.236 Million\n\n\nMar 13 (Reuters) - Savara Q4 operating expenses USD 33.419 million.\n\nQ4 income from operations USD -33.419 million\nQ4 EPS USD -0.13","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nPLX69F9D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194408","title":"Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194408?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:05","pubTimestamp":1773403500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nTUA6RKCLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194472","title":"Savara Q4 EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194472?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:05","pubTimestamp":1773403500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nPLX69F9D3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618504920","title":"How FDA’s No-Advisory-Committee Path for MOLBREEVI Could Shape Savara (SVRA) Investors’ Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2618504920","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618504920?lang=en_us&edition=fundamental","pubTime":"2026-03-12 02:19","pubTimestamp":1773253177,"startTime":"0","endTime":"0","summary":"Savara recently reported that the FDA’s Day 74 Letter for its MOLBREEVI Biologics License Application for autoimmune pulmonary alveolar proteinosis indicated no Advisory Committee meeting is planned and confirmed a PDUFA target action date of August 22, 2026, while European and U.K. marketing applications are also progressing.\nThis combination of streamlined U.S. review signals and parallel regulatory filings in Europe and the U.K. underscores how central MOLBREEVI has become to Savara’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/how-fdas-no-advisory-committee-path-for-molbreevi-could-shap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/how-fdas-no-advisory-committee-path-for-molbreevi-could-shap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","ISBC","SVRA","BK4211","BK4139","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618303879","title":"LifeSci Capital Keeps Their Buy Rating on Savara (SVRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618303879","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618303879?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:55","pubTimestamp":1773143754,"startTime":"0","endTime":"0","summary":"In a report released today, Francois Brisebois from LifeSci Capital reiterated a Buy rating on Savara, with a price target of $11.00. Brisebois cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-savara-svra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-keeps-their-buy-rating-on-savara-svra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618762234","title":"Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Codexis (CDXS) and Diamedica Therapeutics (DMAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618762234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618762234?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:20","pubTimestamp":1773066033,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Savara (SVRA – Research Report), Codexis (CDXS – Res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-savara-svra-codexis-cdxs-and-diamedica-therapeutics-dmac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-savara-svra-codexis-cdxs-and-diamedica-therapeutics-dmac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDXS","BK4121","BK4585","DMAC","LU0029874061.USD","HCSG","XBI","BK4137","BK4581","SVRA","XLV","BK4139","LABU","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617265854","title":"Savara Inc. Publishes Corporate Presentation on Autoimmune PAP and MOLBREEVI Molgramostim Inhalation Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2617265854","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617265854?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:19","pubTimestamp":1772831988,"startTime":"0","endTime":"0","summary":"Savara Inc. released a corporate presentation highlighting its focus on autoimmune pulmonary alveolar proteinosis, a rare chronic lung disease linked to GM-CSF autoantibodies that impair surfactant clearance and can lead to hypoxemic respiratory failure. The presentation describes whole lung lavage as an invasive, non-standardized procedure that may need to be repeated and notes there are no approved drugs in the U.S. or Europe for autoimmune pulmonary alveolar proteinosis. The company also outlines Phase 3 IMPALA-2 data for MOLBREEVI, an investigational inhaled molgramostim administered once daily using a proprietary eFlow nebulizer system. Savara reports statistically significant improvements versus placebo in the primary endpoint, change from baseline in DLCO percent predicted at Week 24, and in DLCO at Week 48, along with additional reported outcomes including changes in St. George’s Respiratory Questionnaire scores and exercise capacity. The presentation states the FDA accepted th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDLbd6Hf0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617165830","title":"Savara announces receipt of Day 74 Letter from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2617165830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617165830?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:15","pubTimestamp":1772831714,"startTime":"0","endTime":"0","summary":"Savara (SVRA) announced that it has received the Day 74 Letter from the FDA which indicated that an Advisory Committee meeting is not planned for t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-announces-receipt-of-day-74-letter-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-announces-receipt-of-day-74-letter-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617658841","title":"BRIEF-Savara Provides Regulatory Update On The MOLBREEVI* Development Program In Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658841?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:12","pubTimestamp":1772831576,"startTime":"0","endTime":"0","summary":"BRIEF-Savara Provides Regulatory Update On The MOLBREEVI* Development Program In Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)March 6 (Reuters) - Savara Inc SVRA.O:SAVARA PROVIDES REGULAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZU1E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630076","title":"Savara Inc - on Track to Submit Maa to UK Mhra by End of Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630076?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831133,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZU1E2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630058","title":"Savara Inc - Pdufa Target Action Date for Molbreevi Set for August 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630058?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831133,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZU1E2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630032","title":"Savara - Day 74 Letter Received From  U.S. Food and Drug Administration Indicated Agency Has No Plans to Convene  Advisory Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630032?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831133,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZU1E2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617063075","title":"Savara Provides Regulatory Update on the Molbreevi* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617063075","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617063075?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831133,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nFWN3ZU1E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617586526","title":"Savara says FDA plans no advisory panel for MOLBREEVI as review continues toward Aug. 22, 2026 PDUFA date","url":"https://stock-news.laohu8.com/highlight/detail?id=2617586526","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617586526?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:05","pubTimestamp":1772831122,"startTime":"0","endTime":"0","summary":"Savara Inc. said the FDA’s Day 74 letter for its MOLBREEVI biologics license application in autoimmune pulmonary alveolar proteinosis indicated no advisory committee meeting is planned. The FDA review is ongoing with a PDUFA target action date of Aug. 22, 2026. Savara also submitted a marketing authorization application to the European Medicines Agency for MOLBREEVI in autoimmune pulmonary alveolar proteinosis. The company said a U.K. MHRA submission remains on track by the end of Q1 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL4nMgSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":105,"code":"91000000","status":"200"}]}}